Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives
International Journal of Molecular Sciences · 11.12.2025 · 26 (24) · 11961
DOI: 10.3390/ijms262411961 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.12.2025. Verfasst von Martina Astore und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Signal Transduction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 269 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (iCCA) is an aggressive cancer arising within the liver from the bile ducts, and it is characterized by limited therapeutic options and a poor prognosis. This neoplasm exhibits both high intra-tumor and inter-tumor heterogeneity and many oncogenic and tumor suppressor genes are involved in its development and progression. Here, we summarize the major pathways and driver genes involved in the genesis and progression of iCCA, with a special look at their potential therapeutic values. We approach not only the well–known FGFR, IDH and HER2 alterations but also delve into less known cellular pathways such as cell surface receptors, cellular signaling pathways, tumor suppressor genes and metabolic pathways. The aim of our review is therefore not only to summarize the available evidence on singular pathways/alterations but also to foster and promote new investigations into lesser known alterations that could be present in each singular iCCA case.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy.
- S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.
- Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Osteoncologia Sarcomi dell'Osso e dei Tessuti Molli e Terapie Innovative, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
ORCID-Profile: Andrea Monte, Chiara Deiana, Alessandro Rizzo, Simona Tavolari, Andrea Palloni, Giorgio Frega
Zitieren
APA
Astore, M., Fabbri, L., Monte, A., Deiana, C., Rizzo, A., Tavolari, S., Deserti, M., Brandi, G., Palloni, A., & Frega, G. (2025). Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives. International Journal of Molecular Sciences, 26(24), 11961. https://doi.org/10.3390/ijms262411961
Vancouver
Astore M, Fabbri L, Monte A, Deiana C, Rizzo A, Tavolari S, et al. Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives. International Journal of Molecular Sciences. 2025;26(24):11961. doi:10.3390/ijms262411961
BibTeX
@article{Astore2025,
author = {Astore, Martina and Fabbri, Laura and Monte, Andrea and Deiana, Chiara and Rizzo, Alessandro and Tavolari, Simona and Deserti, Marzia and Brandi, Giovanni and Palloni, Andrea and Frega, Giorgio},
title = {Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {24},
pages = {11961},
doi = {10.3390/ijms262411961}
}
EUVIMED